Whitehead Connects presents Doug Fambrough

Fambrough-Web-HeadshotDoug Fambrough

CEO of  Dicerna Pharmaceuticals

Douglas Fambrough is a co-founder of Dicerna Pharmaceuticals and joined the company as CEO in May 2010. Prior to joining Dicerna, Dr. Fambrough spent over a decade as a biotechnology venture capitalist with Oxford Bioscience Partners, one of Dicerna’s investors.  Read more below.

“Biologists in Business: Not a bad match!”

December 4, 2014
5:30 pm presentation; 6:30 pm networking reception
Whitehead Institute
Nine Cambridge Center, Cambridge, MA 02142

About Doug Fambrough

Douglas Fambrough is a co-founder of Dicerna Pharmaceuticals and joined the company as CEO in May 2010. Prior to joining Dicerna, Dr. Fambrough spent over a decade as a biotechnology venture capitalist with Oxford Bioscience Partners, one of Dicerna’s investors. At Oxford, he specialized in financing innovative life science technology companies such as the first generation RNA interference company, Sirna Therapeutics (acquired by Merck). Among his other investments are high-throughput DNA sequencing pioneer Solexa (acquired by Illumina); Xencor, which engineers antibody Fc domains to enhance drug properties; Rib-X Pharmaceuticals, a developer of antibiotics against multi-drug resistant pathogens; and Solstice Neurosciences (acquired by US WorldMeds). Prior to Oxford, Dr. Fambrough was a genomic scientist at the Whitehead/MIT Center for Genome Research (now known as the Broad Institute).  Dr. Fambrough graduated from Cornell University and holds a Ph.D. in genetics from the University of California, Berkeley.

About Whitehead Connects

Whitehead Connects is a new initiative that brings renowned biology and biotech leaders to Whitehead Institute to share lessons learned from careers at the nexus of academic science and industry.  Join us for a free, public lecture on December 4 – the second in our 2014-2015 series.  Following the lecture, participants will have the opportunity to meet Whitehead postdoctoral fellows and learn about their latest discoveries.

Upcoming Whitehead Connects Events

March 19, 2015: Daphne Zohar, Founder and Managing Partner, PureTech Ventures